To examine how the relationship between CD3E expression and PDCD1 expression influences response to anti-PD-1 therapy, we analyzed RNA-Seq transcriptome data from pretreatment samples of 26 metastatic melanoma patients who received anti-PD-1 therapy [82]. The gene discussed is PDCD1; the disease is metastatic melanoma.